期刊文献+

肿瘤基因治疗中两种新的靶向分子

Two Molecules as New Targets in the Gene Therapy of Cancer
原文传递
导出
摘要 肿瘤基因治疗通过适当的载体在肿瘤细胞中表达抗癌基因以治疗癌症。目前肿瘤细胞中发现很多重要的致癌相关分子,它们有些与肿瘤细胞无限繁殖密切相关,有些能够抑制细胞的凋亡,有些能够促进肿瘤细胞血管新生或者逃避免疫监视。这些分子无疑是今后肿瘤基因治疗中的理想靶向分子。本文选取了目前肿瘤基因治疗研究中较新并具有一定代表性的2种致癌相关分子:缺氧诱导因子1(HIF-1)、信号转导与转录活化因子3/5(STAT3/5),对其特点及其在癌症治疗中的应用作一综述。 The gene therapy of cancer is a cancer-treatment technique by expressing anticancer genes in tumor cells by rationally designed vectors. Nowadays, more and more crucial molecules in tumor cells have been identified that are related to the unlimited proliferation of cancer cells. Some can inhibit the apoptosis, some can promote angiogenesis, and some can help tumor cell evade immune surveillance. These molecules are ideal targets in future cancer gene therapy. This article reviews the features and the application of two important molecules in tumor cells: hypoxia-inducible factor 1 ( HIF-1 ), signal transducer and activator of transcription 3/5 (STAT3/5)
出处 《医学分子生物学杂志》 CAS CSCD 2005年第5期392-394,398,共4页 Journal of Medical Molecular Biology
基金 国家自然科学基金(No.30120160823)国家高新技术研究发展计划资助项目(863计划)(No.2002AA216021)国家重点基础研究发展规划项目(973计划)(No.2004CB518804)~~
关键词 肿瘤基因治疗 HIF-1 STAT3/5 cancer gene therapy HIF-1 STAT3/5
  • 相关文献

参考文献20

  • 1Darnell J. Transcription factors as targets for cancer therapy. Nat Rev Cancer, 2002, 2 (10): 740-9.
  • 2Talks KL, Helen T, Kevin CG, et al. The expression and distribution of the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol, 2000, 157(2): 411-21.
  • 3Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1)and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res, 2000, 20 (3A): 1527-33.
  • 4Birner P, Monika S, Andreas O, et al. Expression of hypoxia-inducible factor lα in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res, 2001, 7 (6): 1 661-8.
  • 5Mandriota SJ, Turner KJ, Davies DR, et al. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron.Cancer Cell, 2002, 1 (5): 459-68.
  • 6Unruh A, Ressel A, Mohamed HG, et al. The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene, 2003, 22 (21): 3 213-20.
  • 7Zagzag D, Nomura M, Friedlander DR, et al. Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion. J Cell Physiol, 2003, 196 (2): 394-402.
  • 8Cho WK, Seong YR, Lee YH, et al. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor. Mol Ther, 2004, 10(5): 938-49.
  • 9Egan S and Weinberg R. The pathway to signal achievement. Nature, 1993, 365 (6 449): 781-3.
  • 10Turkson J, Tammy B, Roy G, et al. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol, 1998, 18 (5): 2 545-52.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部